|
RU2196769C2
(ru)
*
|
1995-08-30 |
2003-01-20 |
Джи. Ди. Сирл Энд Ко. |
Производные аминобензойной кислоты, фармацевтическая композиция
|
|
ATE234812T1
(de)
*
|
1996-12-09 |
2003-04-15 |
Lilly Co Eli |
Integrin antagonisten
|
|
US6245809B1
(en)
|
1996-12-09 |
2001-06-12 |
Cor Therapeutics Inc. |
Integrin antagonists
|
|
WO1998057173A1
(en)
*
|
1997-06-10 |
1998-12-17 |
Eli Lilly And Company |
Combinatorial process for preparing substituted phenylalanine libraries
|
|
SI1005445T1
(en)
*
|
1997-08-22 |
2004-12-31 |
F. Hoffmann-La Roche Ag |
N-alkanoylphenylalanine derivatives
|
|
US6229011B1
(en)
|
1997-08-22 |
2001-05-08 |
Hoffman-La Roche Inc. |
N-aroylphenylalanine derivative VCAM-1 inhibitors
|
|
US6455550B1
(en)
|
1997-08-22 |
2002-09-24 |
Hoffmann-La Roche Inc. |
N-alkanoylphenylalanine derivatives
|
|
CN100369888C
(zh)
*
|
1997-08-22 |
2008-02-20 |
霍夫曼-拉罗奇有限公司 |
芳酰基苯丙氨酸衍生物
|
|
WO1999011657A1
(en)
*
|
1997-08-29 |
1999-03-11 |
Proteus Molecular Design Ltd. |
1-amino-7-isoquinoline derivatives as serine protease inhibitors
|
|
US6740682B2
(en)
|
1997-08-29 |
2004-05-25 |
Tularik Limited |
Meta-benzamidine derivatives as serine protease inhibitors
|
|
DE69835688T2
(de)
|
1997-10-31 |
2007-10-04 |
Aventis Pharma Ltd., West Malling |
Substituierte anilide
|
|
ES2235383T3
(es)
*
|
1997-12-23 |
2005-07-01 |
Aventis Pharma Limited |
Beta-alaninas sustituidas.
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
ES2226413T3
(es)
*
|
1998-02-26 |
2005-03-16 |
Celltech Therapeutics Limited |
Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
NZ507222A
(en)
|
1998-04-09 |
2003-05-30 |
Meiji Seika Kaisha |
Aminopiperidine derivatives useful as integrin antagonists
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9811969D0
(en)
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9812088D0
(en)
|
1998-06-05 |
1998-08-05 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
*
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6677360B2
(en)
|
1998-12-16 |
2004-01-13 |
Bayer Aktiengesellschaft |
Biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
PL348260A1
(en)
*
|
1998-12-16 |
2002-05-20 |
Bayer Ag |
New biphenyl and biphenyl-analogous compounds as integrin antagonists
|
|
CA2356929A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6291503B1
(en)
|
1999-01-15 |
2001-09-18 |
Bayer Aktiengesellschaft |
β-phenylalanine derivatives as integrin antagonists
|
|
US6344484B1
(en)
*
|
1999-02-12 |
2002-02-05 |
3-Dimensional Pharmaceuticals, Inc. |
Tyrosine alkoxyguanidines as integrin inhibitors
|
|
DE60014588T2
(de)
*
|
1999-02-18 |
2006-02-23 |
F. Hoffmann-La Roche Ag |
Thioamidderivate
|
|
DE60010049T2
(de)
*
|
1999-02-18 |
2005-03-31 |
F. Hoffmann-La Roche Ag |
Phenylalaninolderivate
|
|
FR2792314B1
(fr)
*
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
AU6316900A
(en)
|
1999-08-05 |
2001-03-05 |
Meiji Seika Kaisha Ltd. |
Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alphavbeta3antagonism
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
AU7711000A
(en)
|
1999-09-29 |
2001-04-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Isonipecotamides for the treatment of integrin-mediated disorders
|
|
WO2001032610A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Kaken Pharmaceutical Co., Ltd. |
Urea derivative, process for producing the same, and medicine containing the urea derivative
|
|
US6734205B2
(en)
|
1999-12-16 |
2004-05-11 |
Sumitomo Pharmaceuticals Company Limited |
Substituted guanidine derivatives
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
EP1250935A1
(en)
*
|
2000-01-25 |
2002-10-23 |
Meiji Seika Kaisha Ltd. |
REMEDIES FOR REPERFUSION INJURY CONTAINING INTEGRIN ALPHAvBETA3 ANTAGONIST
|
|
WO2001056607A1
(en)
*
|
2000-02-03 |
2001-08-09 |
Eisai Co., Ltd. |
Integrin expression inhibitors
|
|
DE60130910T2
(de)
|
2000-04-17 |
2008-07-10 |
Ucb Pharma, S.A. |
Enamin-derivate als zell-adhäsionsmoleküle
|
|
GB0011817D0
(en)
*
|
2000-05-16 |
2000-07-05 |
Pharmacia & Upjohn Spa |
Antagonists of integrin receptors
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
DE10032256C2
(de)
*
|
2000-07-03 |
2003-06-05 |
Infineon Technologies Ag |
Chip-ID-Register-Anordnung
|
|
US6740654B2
(en)
|
2000-07-07 |
2004-05-25 |
Celltech R & D Limited |
Squaric acid derivatives
|
|
US7015216B2
(en)
|
2000-07-21 |
2006-03-21 |
Elan Pharmaceuticals, Inc. |
Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
|
|
AU2001275724A1
(en)
|
2000-08-02 |
2002-02-13 |
Celltech R&D Limited |
3-substituted isoquinolin-1-yl derivatives
|
|
AU2001281059A1
(en)
*
|
2000-08-02 |
2002-02-13 |
Smith Kline Beecham Corporation |
Fatty acid synthase inhibitors
|
|
US6486174B2
(en)
|
2000-08-07 |
2002-11-26 |
3-Dimensional Pharmaceuticals, Inc. |
Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
|
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
WO2002014272A1
(en)
*
|
2000-08-09 |
2002-02-21 |
Kaken Pharmaceutical Co., Ltd. |
(thio)urea derivatives, process for their production and medicines containing the derivatives
|
|
DZ3415A1
(fr)
|
2000-08-31 |
2002-03-07 |
Chiron Corp |
Guanidinobenzamides comme mc4-r agonistes.
|
|
CA2436130A1
(en)
*
|
2001-01-29 |
2002-08-08 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted indoles and their use as integrin antagonists
|
|
ITTO20010110A1
(it)
|
2001-02-08 |
2002-08-08 |
Rotta Research Lab |
Nuovi derivati benzamidinici dotati di attivita' anti-infiammatoria ed immunosoppressiva.
|
|
PT1385823E
(pt)
|
2001-04-09 |
2007-01-31 |
Novartis Vaccines & Diagnostic |
Compostos de guanidino como agonistas do receptor de melanocortina-4 (r-mc4)
|
|
JP2004529918A
(ja)
|
2001-04-09 |
2004-09-30 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物
|
|
US6872730B2
(en)
|
2001-04-27 |
2005-03-29 |
3-Dimensional Pharmaceuticals, Inc. |
Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
|
|
KR20040058229A
(ko)
|
2001-10-22 |
2004-07-03 |
더 스크립스 리서치 인스티튜트 |
항체 표적화 화합물
|
|
US20030207814A1
(en)
*
|
2002-02-04 |
2003-11-06 |
Chiron Corporation |
Novel guanidinyl derivatives
|
|
US20050124652A1
(en)
*
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
|
US20030195187A1
(en)
*
|
2002-02-04 |
2003-10-16 |
Chiron Corporation |
Guanidino compounds
|
|
US20070004743A1
(en)
*
|
2002-02-25 |
2007-01-04 |
Xiao Linda L |
Intranasal administration of mc4-r agonists
|
|
DE60333937D1
(de)
*
|
2002-05-23 |
2010-10-07 |
Novartis Vaccines & Diagnostic |
Substituierte quinazolinone verbindungen
|
|
KR20060018217A
(ko)
*
|
2003-05-23 |
2006-02-28 |
카이론 코포레이션 |
Ｍｃ4-ｒ 작용제로서 구아니디노-치환된 퀴나졸리논 화합물
|
|
ATE439837T1
(de)
*
|
2003-06-03 |
2009-09-15 |
Novartis Ag |
5-gliedrige heterocyclische p-38 inhibitoren
|
|
WO2005051391A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Chiron Corporation |
Quinazolinone compounds with reduced bioaccumulation
|
|
US20070122408A1
(en)
*
|
2005-10-20 |
2007-05-31 |
The Scripps Research Institute |
Fc Labeling for Immunostaining and Immunotargeting
|
|
CA2654822A1
(en)
|
2006-06-20 |
2007-12-27 |
F. Hoffmann-La Roche Ag |
Arylsulfonyl naphthalene derivatives and uses thereof
|
|
US8518927B2
(en)
|
2009-02-10 |
2013-08-27 |
The Scripps Research Institute |
Chemically programmed vaccination
|
|
US20140010783A1
(en)
*
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
|
US8716226B2
(en)
|
2012-07-18 |
2014-05-06 |
Saint Louis University |
3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
|
|
US9085606B2
(en)
|
2012-07-18 |
2015-07-21 |
Saint Louis University |
Beta amino acid derivatives as integrin antagonists
|
|
KR20180107121A
(ko)
|
2015-12-30 |
2018-10-01 |
세인트 루이스 유니버시티 |
팬 인테그린 길항제로서의 메타-아자사이클릭 아미노 벤조산 유도체
|
|
CN107652210B
(zh)
*
|
2017-09-30 |
2021-01-01 |
瑞阳（上海）新药研发有限公司 |
一种胍类化合物或其药学上可接受的盐、其制备方法和应用
|